Cargando…
EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
Epstein–Barr virus (EBV) was the first oncogenic virus identified in humans. It is primarily associated with multiple lymphoid and epithelial cancers, including nasopharyngeal carcinoma (NPC). However, its association with ferroptosis and its role in cancer therapy resistance have not been fully elu...
Autores principales: | Yuan, Li, Li, Shibing, Chen, Qiuyan, Xia, Tianliang, Luo, Donghua, Li, Liangji, Liu, Sailan, Guo, Shanshan, Liu, Liting, Du, Chaochao, Jia, Guodong, Li, Xiaoyun, Lu, Zijian, Yang, Zhenchong, Liu, Huanliang, Mai, Haiqiang, Tang, Linquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346003/ https://www.ncbi.nlm.nih.gov/pubmed/35105963 http://dx.doi.org/10.1038/s41418-022-00939-8 |
Ejemplares similares
-
Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
por: Lu, Hui, et al.
Publicado: (2022) -
Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection
por: Li, Xiaoyun, et al.
Publicado: (2020) -
Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [(18)F]FDG PET/CT parameters
por: Dongxiang, Wen, et al.
Publicado: (2022) -
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023) -
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
por: Liu, Lizhen, et al.
Publicado: (2023)